Advancing paediatric allergy care: key findings from the largest trial of house dust mite sublingual immunotherapy-tablets in children.
作者信息
Schoos Ann-Marie Malby, Chawes Bo
机构信息
COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Department of Paediatrics, Slagelse Hospital, Slagelse, Denmark.
出版信息
Lancet Reg Health Eur. 2024 Dec 12;48:101167. doi: 10.1016/j.lanepe.2024.101167. eCollection 2025 Jan.
Abstract
摘要
相似文献
1
Advancing paediatric allergy care: key findings from the largest trial of house dust mite sublingual immunotherapy-tablets in children.推进儿童过敏治疗：儿童尘螨舌下免疫治疗片剂最大规模试验的关键发现
Lancet Reg Health Eur. 2024 Dec 12;48:101167. doi: 10.1016/j.lanepe.2024.101167. eCollection 2025 Jan.
2
Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.基层医疗中针对屋尘螨过敏儿童的舌下免疫疗法随机双盲安慰剂对照试验：研究设计与招募
BMC Fam Pract. 2008 Oct 20;9:59. doi: 10.1186/1471-2296-9-59.
3
Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.尘螨变应性鼻炎患者舌下含服 SQ 屋尘螨滴剂的临床获益。
Allergy. 2017 Oct;72(10):1576-1578. doi: 10.1111/all.13155. Epub 2017 Apr 11.
4
Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.尘螨变应原舌下免疫治疗片剂治疗日本尘螨性变应性鼻炎成人及青少年患者的疗效和安全性。
J Allergy Clin Immunol. 2017 Jun;139(6):1840-1848.e10. doi: 10.1016/j.jaci.2016.09.043. Epub 2016 Nov 15.
5
The impact of adverse reactions on adherence to sublingual immunotherapy for Japanese cedar pollinosis and house dust mite allergy in Japan.不良反应对日本 cedar 花粉过敏和屋尘螨过敏舌下免疫治疗依从性的影响。
Acta Otolaryngol. 2024 Jul-Aug;144(7-8):467-475. doi: 10.1080/00016489.2024.2397054. Epub 2024 Sep 12.
6
Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period.屋尘螨过敏性鼻炎患者的舌下免疫疗法：两年期临床结果的前瞻性研究。
J Laryngol Otol. 2016 Mar;130(3):272-7. doi: 10.1017/S0022215116000025. Epub 2016 Jan 19.
7
Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.舌下过敏片剂中屋尘螨过敏原的生物利用度高度依赖于制剂。
Int Arch Allergy Immunol. 2017;174(1):26-34. doi: 10.1159/000479693. Epub 2017 Sep 27.
8
The Effective Allergenic Reactivity of House Dust Mite Sublingual Immunotherapy Tablets Is Determined by Tablet Formulation.屋尘螨舌下免疫治疗片剂的有效变应原反应性由片剂配方决定。
Biol Pharm Bull. 2019;42(6):1030-1033. doi: 10.1248/bpb.b18-00857.
9
New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.尘螨相关过敏性疾病舌下免疫治疗的新建议
Curr Pharm Biotechnol. 2017;18(5):378-383. doi: 10.2174/1389201018666170417103316.
10
A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis.为期三年的屋尘螨舌下免疫疗法似乎对控制过敏性鼻炎症状有效。
Am J Rhinol Allergy. 2018 May;32(3):147-152. doi: 10.1177/1945892418764966. Epub 2018 Apr 12.
本文引用的文献
1
Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial.SQ屋尘螨舌下免疫治疗片（12 SQ-HDM）用于治疗伴有或不伴有哮喘的变应性鼻炎/鼻结膜炎患儿的疗效和安全性（MT-12）：一项随机、双盲、安慰剂对照的III期试验。
Lancet Reg Health Eur. 2024 Nov 26;48:101136. doi: 10.1016/j.lanepe.2024.101136. eCollection 2025 Jan.
2
Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review.皮下免疫疗法对尘螨过敏哮喘儿童的疗效与安全性：一项荟萃分析与系统评价
Front Pediatr. 2023 Jun 15;11:1137478. doi: 10.3389/fped.2023.1137478. eCollection 2023.
3
Impact of allergic rhinitis on the day-to-day lives of children: insights from an Australian cross-sectional study.变应性鼻炎对儿童日常生活的影响：来自澳大利亚横断面研究的见解。
BMJ Open. 2020 Nov 24;10(11):e038870. doi: 10.1136/bmjopen-2020-038870.
4
International consensus statement on allergy and rhinology: allergic rhinitis-executive summary.国际过敏与鼻科学学会共识声明：变应性鼻炎-执行摘要。
Int Forum Allergy Rhinol. 2018 Feb;8(2):85-107. doi: 10.1002/alr.22070.
5
Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy.5 年 SQ 豚草舌下免疫治疗片剂哮喘预防（GAP）试验结果在儿童花粉过敏症。
J Allergy Clin Immunol. 2018 Feb;141(2):529-538.e13. doi: 10.1016/j.jaci.2017.06.014. Epub 2017 Jul 6.
6
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.一项随机、安慰剂对照试验中，屋尘螨舌下免疫治疗片在北美的青少年和成年人中的疗效。
J Allergy Clin Immunol. 2016 Dec;138(6):1631-1638. doi: 10.1016/j.jaci.2016.06.044. Epub 2016 Aug 10.
7
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens.变应原特异性免疫疗法及对变应原的免疫耐受机制。
World Allergy Organ J. 2015 May 14;8(1):17. doi: 10.1186/s40413-015-0063-2. eCollection 2015.
8
The relevance of allergen exposure to the development of asthma in childhood.变应原暴露与儿童哮喘发生的相关性。
J Allergy Clin Immunol. 2000 Feb;105(2 Pt 2):S503-8. doi: 10.1016/s0091-6749(00)90051-4.
Zotero 插件